menu
    • menu

    Company profile for Artiva Biotherapeutics

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. Artiva Biotherapeutics was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. At Artiv...
    Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. Artiva Biotherapeutics was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. At Artiva, our mission is to deliver highly effective cell therapies that are also safe and immediately available and accessible to any cancer patient who stands to benefit.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Artiva BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4747 Executive Drive #1150 San Diego, CA 92121
    Telephone
    Telephone
    1.858.267.4467
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.artivabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/artivabio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Artiva Biotherapeutics to Present at Jefferies Conference
    Artiva Biotherapeutics to Present at Jefferies Conference

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3302755/0/en/artiva-biotherapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Artiva Biotherapeutics: AlloNK Data at EULAR 2026 Congress
    Artiva Biotherapeutics: AlloNK Data at EULAR 2026 Congress

    19 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/19/3297953/0/en/artiva-biotherapeutics-announces-multiple-allonk-data-presentations-at-eular-2026-congress-including-late-breaking-oral-presentation-highlighting-clinical-efficacy-comparable-to-au.html

    GLOBENEWSWIRE
    19 May 2026
    Share Share
    Artiva Appoints Diego Miralles as President and Head of R&D
    Artiva Appoints Diego Miralles as President and Head of R&D

    19 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/19/3297380/0/en/artiva-biotherapeutics-appoints-veteran-biotech-executive-and-drug-developer-diego-miralles-m-d-as-president-and-head-of-research-and-development.html

    GLOBENEWSWIRE
    19 May 2026
    Share Share
    Artiva Shows AlloNK Autoimmune Data, Plans Phase 3 RA Trial
    Artiva Shows AlloNK Autoimmune Data, Plans Phase 3 RA Trial

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3290957/0/en/artiva-announces-positive-initial-clinical-data-with-allonk-across-multiple-autoimmune-diseases-and-fda-alignment-to-initiate-phase-3-registrational-trial-in-rheumatoid-arthritis-i.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Artiva Biotherapeutics Reports Q1 2026 Results and Highlights
    Artiva Biotherapeutics Reports Q1 2026 Results and Highlights

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3290961/0/en/artiva-biotherapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Artiva Biotherapeutics Prices $300M Stock and Warrant Offering
    Artiva Biotherapeutics Prices $300M Stock and Warrant Offering

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3290975/0/en/artiva-biotherapeutics-announces-pricing-of-300-million-underwritten-offering-of-common-stock-and-pre-funded-warrants.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search